Gemcitabine, dexamethasone and cisplatin with or without rituximab is highly effective as a mobilization regimen in relapsed or refractory lymphoma. // Leukemia Research Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2213048926000063?dgcid=rss_sd_all
Gemcitabine, dexamethasone and cisplatin with or without rituximab is highly effective as a mobilization regimen in relapsed or refractory lymphoma. Leukemia Research Reports. https://www.sciencedirect.com/science/article/pii/S2213048926000063?dgcid=rss_sd_all
“Gemcitabine, dexamethasone and cisplatin with or without rituximab is highly effective as a mobilization regimen in relapsed or refractory lymphoma.” Leukemia Research Reports.
@article{article57852,
title = {Gemcitabine, dexamethasone and cisplatin with or without rituximab is highly effective as a mobilization regimen in relapsed or refractory lymphoma},
journal = {Leukemia Research Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2213048926000063?dgcid=rss_sd_all}
}